Avanir Pharmaceuticals, AstraZeneca, Novartis deal

AVNR announced plans to restructure and focus on Zenvia, a combination of dextromethorphan and a dextromethorphan metabolism inhibitor to treat involuntary emotional

Read the full 220 word article

How to gain access

Continue reading with a
two-week free trial.